Baxter (NYSE:BAX) has closed an offering of senior notes worth approximately $1.68 billion (EU €1.5 billion), according to a recently posted SEC filing.

The Deerfield, Ill.-based company said that it offered $841.3 million (EU €750 million) in 0.4% senior notes due 2024 and $841.3 million (EU €750 million) in 1.3% senior notes due 2029.

The senior notes were sold pursuant to an underwriting agreement inked last week between Baxter, Barclays Bank, Citigroup Global Markets Limited, Merrill Lynch International and other underwriters, according to an SEC filing.

Baxter has not yet stated how it plans to spend funds raised in the offering.

Late last month, Baxter saw share prices dip despite the medical device maker beating expectations on Wall Street with its first quarter 2019 earnings.